Sanofi

Sanofi partners with OpenAI, Formation Bio on AI-driven drug development
Reuters
Tue, 05/21/24 - 07:13 pm
Sanofi
drug development
artificial intelligence
OpenAI
Formation Bio
Despite midstage trial miss, Amgen and AstraZeneca see promise for Tezspire in COPD
Fierce Pharma
Mon, 05/20/24 - 11:25 am
Amgen
AstraZeneca
COPD
Sanofi
Regeneron
Tezspire
Dupixent
Novavax (briefly) becomes meme stock following Sanofi licensing deal
Medical Marketing and Media
Tue, 05/14/24 - 11:01 pm
Novavax
Sanofi
pharma stocks
meme stocks
Novavax's Q1 Results Are Overshadowed by Its Sanofi Partnership
Motley Fool
Mon, 05/13/24 - 10:20 pm
Novavax
earnings
Sanofi
Sanofi pays $80M to add Roche-rivaling Fulcrum drug to phase 3 rare disease pipeline
Fierce Biotech
Mon, 05/13/24 - 11:25 am
Sanofi
Fulcrum Therapeutics
Roche
GSK
Rare Diseases
clinical trials
losmapimod
Maze lands new partner for Pompe drug, after Sanofi pact came apart
BioPharma Dive
Fri, 05/10/24 - 11:29 am
Maze Therapeutics
Pompe disease
Shionogi
FTC
Sanofi
MZE001
Sanofi forges $1.2bn alliance with vaccines firm Novavax
Pharmaphorum
Fri, 05/10/24 - 11:11 am
Sanofi
Novavax
vaccines
COVID-19
Flu
Royalty Pharma pays startup $525M for stake in Sanofi MS drug
BioPharma Dive
Thu, 05/9/24 - 07:13 pm
Sanofi
Royalty Pharma
MS
ImmuNext
frexalimab
Dupixent recaptures top Rx, OTC pharma brand spot in April
Medical Marketing and Media
Wed, 05/8/24 - 11:03 pm
DTC advertising
Dupixent
Sanofi
Regeneron
Sanofi's New Cancer Drug Could Help Deliver a Big Payday
Motley Fool
Wed, 05/8/24 - 11:34 am
Sanofi
rilzabrutinib
Btk inhibitors
clinical trials
Dupixent’s DU More campaign breathes life into asthma treatment space
Medical Marketing and Media
Mon, 04/29/24 - 09:53 am
Dupixent
DTC advertising
Sanofi
Regeneron
AbbVie's Rinvoq conquers Regeneron and Sanofi's Dupixent in eczema trial—again
Fierce Pharma
Fri, 04/26/24 - 11:18 am
AbbVie
Rinvoq
Regeneron
Sanofi
Dupixent
atopic dermatitis
Sanofi and AstraZeneca Scrap Several Early-Stage Programs in Q1
BioSpace
Thu, 04/25/24 - 05:56 pm
Sanofi
AstraZeneca
Sanofi profit slips on generic competition and currency effects
Reuters
Thu, 04/25/24 - 05:47 pm
Sanofi
earnings
generics
Sanofi gears up for approval of its BTK inhibitor, meets Phase III endpoint
Clinical Trials Arena
Tue, 04/23/24 - 10:51 am
Sanofi
rilzabrutinib
Btk inhibitors
ITP
Sanofi's Zantac settlement is worth $100M, or $25K per claimant: Bloomberg
Fierce Pharma
Mon, 04/22/24 - 05:59 pm
Sanofi
legal
Zantac
settlements
Sanofi, busy with cost-savings campaign, restructures US commercial vaccine group
Fierce Pharma
Thu, 04/18/24 - 10:30 pm
Sanofi
restructuring
vaccines
IGM and Sanofi collaboration will pivot to immunology and inflammation
Pharmaceutical Technology
Wed, 04/17/24 - 10:09 pm
Sanofi
IGM Biosciences
immunology
inflammation
Biopharma Layoff Tracker 2024: Genentech, Sanofi, Novartis and More Cut Staff
BioSpace
Thu, 04/11/24 - 10:22 pm
biotech
layoffs
Genentech
Sanofi
Novartis
Sanofi begins 'full pipeline reprioritization' with layoffs in tow, R&D chief tells staff
Fierce Biotech
Fri, 04/5/24 - 11:26 am
Sanofi
R&D
layoffs

Pages